Shares of OptiBiotix Health PLC (LON: OPTI) today surged 10.9% after announcing that all its business divisions were likely to register a profitable year given the significant business activity witnessed during H1 2020.
The company’s interim results indicated that its sales for the six months ended June 30th were up 400% to £744,821, which saw its losses shrink 51% to £605,663 as compared to H1 2019 as its costs narrowed. Optibiotix had £1.47 million in cash at the end of the period.
The company, which makes health and weight loss products based on good bacteria that promote gut health, said that it was considering a dual listing in international markets such as the USA in a bid to raise more capital.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Stephen O’Hara, Optibiotix’s CEO said: “Our products are now being commercialised with large retail and pharmaceutical partners boosting consumer awareness and confidence in our brands with OptiBiotix now being identified as a key player in the microbiome space within industry.”
Adding that:
“We anticipate further change to the management team and board and more commercial agreements in the US as we to continue to evolve the company and build market presence to increase the success of any potential dual listing.”
The CEO expects Optibiotix’s business to grow at a compound annual growth rate of 22.6% from this year up to 2025.
Optibiotix share price
Optibiotix shares today rallied 10.9% to trade at 57p having ended Wednesday’s session trading at 51.4p.
People who read this also read:
